
The Broad Institute brings together a diverse group of individuals from across its partner institutions — undergraduate and graduate students, postdoctoral fellows, professional scientists, administrative professionals, and academic faculty. The culture and environment at the Broad is designed to encourage creativity and to engage all participants, regardless of role or seniority, in the mission of the Institute. Within this setting, researchers are empowered — both intellectually and technically — to confront even the most difficult biomedical challenges. The Institute’s organization is unique among biomedical research institutions. It encompasses three types of organizational units: core member laboratories, programs and platforms. Scientists within these units work closely together — and with other collaborators around the world — to tackle critical problems in human biology and disease.
此公司進入各市場的次序 — 由最舊至最新
Illumina推出TruPath基因組用於遺傳病研究
因美纳推出TruPath Genome用於罕見病研究
註冊以查看完整訊號動態
Broad Institute Of MIT And Harvard 的國際擴張與競爭對手的比較
長條顯示所比較各公司之間的相對規模。
欄位5| 公司 | 市場 | 新市場 | 動能 | 活動 | 擴張評分 |
|---|---|---|---|---|---|
Broad Institute Of MIT And Harvard你 | 0 | 0 | 0% | 0 | 18 |
IP Counsel
查看招聘Cambridge, MA · 3星期前
Senior Director, IT Optimization and Digital Experience
查看招聘Cambridge, MA · 上個月
Research Scientist I - MDL
查看招聘Cambridge, MA · 前日
無進行中的廣告活動
註冊以追蹤此公司,並在發生變化時第一時間獲得提醒。
丹娜-法伯癌症研究所的試驗顯示,個人化癌症疫苗對III/IV期透明細胞腎癌患者有效,九名參與者接受治療後均未復發。
因美纳推出TruPath Genome,為罕見病研究提供全面基因組洞察,簡化工作流程,提高難解基因組區域的準確性。
解鎖已驗證電郵與直撥電話
免費 · 無需信用卡
關於 Broad Institute Of MIT And Harvard 業務、市場及增長訊號的快速解答。
